Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Ureteroenteric anastomotic strictures after radical cystectomy-does operative approach matter?
|
J Urol
|
2012
|
3.30
|
2
|
Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma.
|
Eur Urol
|
2011
|
2.51
|
3
|
Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series.
|
J Urol
|
2010
|
2.39
|
4
|
Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer.
|
J Urol
|
2010
|
2.03
|
5
|
Recovery of urinary function after radical prostatectomy: identification of trajectory cluster groups.
|
J Urol
|
2012
|
1.98
|
6
|
Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline.
|
J Urol
|
2012
|
1.85
|
7
|
National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats.
|
J Urol
|
2012
|
1.84
|
8
|
Volume outcomes of cystectomy--is it the surgeon or the setting?
|
J Urol
|
2012
|
1.77
|
9
|
Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy.
|
Eur Urol
|
2007
|
1.76
|
10
|
Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer.
|
J Urol
|
2011
|
1.72
|
11
|
Comparison of transfusion requirements between open and robotic-assisted laparoscopic radical prostatectomy.
|
BJU Int
|
2010
|
1.66
|
12
|
Smaller prostate size predicts high grade prostate cancer at final pathology.
|
J Urol
|
2010
|
1.62
|
13
|
Psychometric characteristics of a condition-specific, health-related quality-of-life survey: the FACT-Vanderbilt Cystectomy Index.
|
Urology
|
2012
|
1.56
|
14
|
Impact of positive apical surgical margins on likelihood of biochemical recurrence after radical prostatectomy.
|
J Urol
|
2009
|
1.55
|
15
|
Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients.
|
Urology
|
2012
|
1.53
|
16
|
Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer.
|
J Urol
|
2010
|
1.50
|
17
|
Robotic vs open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy.
|
BJU Int
|
2007
|
1.50
|
18
|
Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
|
Cancer
|
2009
|
1.41
|
19
|
The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer.
|
Urol Oncol
|
2011
|
1.01
|
20
|
Obesity, body composition, and prostate cancer.
|
BMC Cancer
|
2012
|
1.00
|
21
|
Successful control of schistosomiasis and the changing epidemiology of bladder cancer in Egypt.
|
BJU Int
|
2010
|
1.00
|
22
|
Prostate Cancer Early Detection, Version 2.2015.
|
J Natl Compr Canc Netw
|
2015
|
0.98
|
23
|
The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial update.
|
BJU Int
|
2015
|
0.97
|
24
|
The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer.
|
Cancer Causes Control
|
2010
|
0.97
|
25
|
Gender, race, and variation in the evaluation of microscopic hematuria among Medicare beneficiaries.
|
J Gen Intern Med
|
2014
|
0.96
|
26
|
ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma.
|
BJU Int
|
2012
|
0.96
|
27
|
Centralization of radical prostatectomy in the United States.
|
J Urol
|
2012
|
0.95
|
28
|
Immediate surgical outcomes for radical prostatectomy in the University HealthSystem Consortium Clinical Data Base: the impact of hospital case volume, hospital size and geographical region on 48,000 patients.
|
BJU Int
|
2009
|
0.95
|
29
|
Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy.
|
J Urol
|
2011
|
0.92
|
30
|
Gleason 6 Prostate Cancer: Translating Biology into Population Health.
|
J Urol
|
2015
|
0.91
|
31
|
Anatomic basis for lymph node counts as measure of lymph node dissection extent: a cadaveric study.
|
Urology
|
2013
|
0.90
|
32
|
Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experience.
|
J Urol
|
2012
|
0.89
|
33
|
Tumour size, tumour complexity, and surgical approach are associated with nephrectomy type in small renal cortical tumours treated electively.
|
BJU Int
|
2011
|
0.89
|
34
|
Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer--evidence of effect modification by prostate size.
|
Cancer Lett
|
2012
|
0.88
|
35
|
Determining factors for hospital discharge status after radical cystectomy in a large contemporary cohort.
|
J Urol
|
2010
|
0.86
|
36
|
Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment.
|
Cancer
|
2014
|
0.86
|
37
|
Impact of Adherence to Quality Measures for Localized Prostate Cancer on Patient-reported Health-related Quality of Life Outcomes, Patient Satisfaction, and Treatment-related Complications.
|
Med Care
|
2016
|
0.84
|
38
|
Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy.
|
J Urol
|
2009
|
0.83
|
39
|
Prostate-specific antigen screening in a high-risk population: lessons from the community and how they relate to large-scale population-based studies.
|
Urology
|
2005
|
0.83
|
40
|
Comparative analysis of whole mount processing and systematic sampling of radical prostatectomy specimens: pathological outcomes and risk of biochemical recurrence.
|
J Urol
|
2010
|
0.80
|
41
|
Knowledge of the harms of tobacco use among patients with bladder cancer.
|
Cancer
|
2014
|
0.80
|
42
|
Effect of a large prostate gland on open and robotically assisted laparoscopic radical prostatectomy.
|
BJU Int
|
2008
|
0.80
|
43
|
Tumor volume as a predictor of adverse pathologic features and biochemical recurrence (BCR) in radical prostatectomy specimens: a tale of two methods.
|
World J Urol
|
2010
|
0.79
|
44
|
Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer.
|
BJU Int
|
2009
|
0.78
|
45
|
Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy.
|
BJU Int
|
2014
|
0.78
|
46
|
Radical nephrectomy surgical outcomes in the University HealthSystem Consortium Data Base: Impact of hospital case volume, hospital size, and geographic location on 40,000 patients.
|
Cancer
|
2009
|
0.77
|
47
|
Editorial comment.
|
J Urol
|
2012
|
0.75
|
48
|
Editorial comment.
|
J Urol
|
2011
|
0.75
|
49
|
Editorial comment.
|
J Urol
|
2010
|
0.75
|
50
|
Re: A multi-institution, minimally invasive urological oncology fellowship: a critical assessment of the clinical training and academic benefits. J. A. Brown and R. W. Lewis, J Urol 2006; 176: 2619-2623.
|
J Urol
|
2007
|
0.75
|
51
|
Delivering high-quality care to prostate cancer survivors.
|
Cancer
|
2013
|
0.75
|
52
|
Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
|
J Urol
|
2008
|
0.75
|
53
|
Short term complications from transurethral resection of bladder tumor.
|
Can J Urol
|
2016
|
0.75
|
54
|
The influence of provider characteristics and market forces on response to financial incentives.
|
Am J Manag Care
|
2017
|
0.75
|
55
|
Improving quality through clinical registries in urology.
|
Curr Opin Urol
|
2017
|
0.75
|
56
|
Outcomes session.
|
Urol Oncol
|
2012
|
0.75
|
57
|
A urologic oncology roundtable discussion: the role of disease monitoring in treatment decision-making for patients with metastatic castration-resistant prostate cancer.
|
Hosp Pract (1995)
|
2013
|
0.75
|